Cytoprotective actions of 2,4‐dimethoxybenzylidene anabaseine in differentiated PC12 cells and septal cholinergic neurons

Drug Development Research

Volumn 31, Issue 2, 1994, Pages 135-141

  Martin, Eileen J ^a   Panickar, Kiran S ^a   King, Michael A ^a   Deyrup, Malgorzata ^a   Hunter, Bruce E ^a   Wang, Geehuan ^a   Meyer, Edwin M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

cytoprotection; dimethoxybenzylidene anabaseine; PC12 cells; septal neurons

Indexed keywords

2,4 DIMETHOXYBENZYLIDENEANABASEINE; ANABASINE DERIVATIVE; LACTATE DEHYDROGENASE; MECAMYLAMINE; NERVE GROWTH FACTOR; NICOTINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT;

EID: 0028194977     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.430310208     Document Type: Article

References (26)

1. The nerve growth factor: Purification as a 30,000‐molecular‐weight protein
2. A role for the alpha‐bungarotoxin/thymopoietin receptor in neurite outgrowth in PC12 cells
3. A neuronal nicotinic acetylcholine receptor subunit (α‐7) is developmentally regulated and forms a homo‐oligomeric channel blocked by alpha‐bungarotoxin
4. Effects of nerve growth factor on cholinergic brain neurons
5. Gangliosides rescue neuronal cells from death after trophic factor deprivation
6. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up‐regulated by chronic nicotine treatment
7. Possible regulatory function of acetylcholine receptor in maintenance of retinotectal synapses
8. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor
9. Potential pharmacological use of neurotrophic factors in the treatment of neuro‐degenerative diseases
10. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with septo‐hippocampal lesions
11. Chronic nicotine treatment counteracts the disappearance of tyrosine‐hydroxylase immuno‐reactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemi‐transection
12. 2+ determine nerve growth factor dependence of sympathetic ganglion cells
13. The role of NGF/protein kinase C interactions in differentiation versus maintenance of PC12 cells
14. Effects of anabaseine–related analogs on rat brain nicotinic receptor binding and on avoidance behaviors
15. 3H]Cytisine binding to nicotinic cholinergic receptors in brain
16. Potential use of nerve growth factor to treat Alzeimer's Disease
17. Neuronal nicotinic alpha‐bungarotoxin sites
18. Multiple agents rescue PC12 cells from serum‐free cell death by translation‐ and transcription‐independent mechanisms
19. Molecular cloning, functional properties, and distribution of rat brain α7: A nicotinic cation channel highly permeable to calcium
20. Long term effects of nicotine and pilocarpine on neocortical neuronal density and GABA uptake in nucleus basalis lesioned rats
21. Cholinergic‐peptide interactions in vivo: Molecular to behavioral considerations
22. How many kinds of nicotinic acetylcholine receptor are there?
23. 2+
24. Lactate dehydrogenase activity in blood
25. Long range transmission of polar effects in cholinergic 3‐arylidene anabaseines. Conformations calculated by molecular modelling